Filana Therapeutics
FLNA
97 hedge funds and large institutions have $22.1M invested in Filana Therapeutics in 2025 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 23 increasing their positions, 33 reducing their positions, and 38 closing their positions.
77% more call options, than puts
Call options by funds: $2.27M | Put options by funds: $1.29M
7.41% less ownership
Funds ownership: 32.73% → 25.33% (-7.4%)
13% less capital invested
Capital invested by funds: $25.6M → $22.1M (-$3.42M)
17% less funds holding
Funds holding: 117 → 97 (-20)
30% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 33
53% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 38
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$841K |
| 2 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$551K |
| 3 |
SPS
Susquehanna Portfolio Strategies
Bala Cynwyd,
Pennsylvania
|
+$237K |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$216K |
| 5 |
Goldman Sachs
New York
|
+$208K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$3.43M |
| 2 |
N
Nuveen
Charlotte,
North Carolina
|
-$1.95M |
| 3 |
State Street
Boston,
Massachusetts
|
-$1.17M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$896K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$633K |
FLNA Hedge Fund Activity: Q2 2025 in Review
97 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q2 2025, worth a combined $22.1M — down 13% from $25.6M a quarter earlier.
Sellers outnumbered buyers: 38 funds closed out of FLNA and 18 opened new positions — a net loss of 20 holders — while 33 trimmed existing stakes and 23 added.
The largest buyer was Millennium Management, opening a new position worth an estimated $841K. The largest seller was BlackRock, cutting an estimated $3.43M.
- 97 institutional investors held Filana Therapeutics (FLNA) as of Q2 2025, down from 117 in Q1 2025.
- Funds reported $22.1M of Filana Therapeutics stock for Q2 2025, down 13% quarter-over-quarter.
- 18 funds opened new Filana Therapeutics positions in Q2 2025 and 38 closed out, a net change of -20 holders.
- The largest Filana Therapeutics buyer in Q2 2025 was Millennium Management, an estimated $841K added.
- The largest Filana Therapeutics seller in Q2 2025 was BlackRock, an estimated $3.43M sold.
Based on aggregated 13F filings for Q2 2025.